The Valley Desk

NCT00528996 · Interventional trial

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

Overall registry status Completed

Phase 2

Conditions Pulmonary Disease, Chronic Obstructive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov